Methods for the treatment of anxiety and for identification of anxiolytic agents

Details for Australian Patent Application No. 2006283106 (hide)

Owner Wyeth

Inventors Beyer, Chad Edward; Mark, Robert John

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006283106

PCT Pub. Number WO2007/024946

Priority 60/710,385 23.08.05 US

Filing date 23 August 2006

Wipo publication date 1 March 2007

International Classifications

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/024946 Priority application(s): WO2007/024946

24 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283109-Alpha2C adrenoreceptor agonists

2006283105-Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase